Larvol Delta - Bicara-Therapeutics-Preliminary-Phase-1b-Expansion-Cohort-Data-Evaluating-750mg-of-Ficerafusp-Alfa-Weekly-Plus-Pembrolizumab-Advances-Pivotal-Study-Dose-Selection-on-Track-for-First-Quarter-2026

ficerafusp alfa (BCA101) - Biocon

https://www.globenewswire.com/news-release/2025/12/06/3201043/0/en/Bicara-Therapeutics-Preliminary-Phase-1b-Expansion-Cohort-Data-Evaluating-750mg-of-Ficerafusp-Alfa-Weekly-Plus-Pembrolizumab-Advances-Pivotal-Study-Dose-Selection-on-Track-for-Firs.html

Dec 6, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next